Posted by 
In June of last year, I discussed the results of a large epidemiological study in women that showed that women with larger breasts have an increased risk of developing type-2 diabetes.
As soon as Travis and I read this study, we knew we had to do a follow-up study of our own to see if this finding was simply spurious or if there was actually something to large breasts that indicated health risk – beyond that explained by obesity per se.
The project that Travis and I began over a year ago has culminated in both a hot-off-the-press publication in the journal Obesity, as well as my presentation at this year’s Obesity Society meeting in Washington D.C.
In the study, we used body composition data acquired through MRI on about 100 premenopausal women to directly quantify breast size. By using MRI data we significantly improved the methodology used by the authors of the original study on breast size and diabetes risk, who relied on over 20 year recall of cup size as their key measure.
First, we sought to examine if breast tissue volume was associated with any cardiometabolic risk factors, such as glucose tolerance (a known antecedent to type 2 diabetes) and various blood lipids. Since the original authors found an association between cup size and diabetes risk, we expected to find an association between breast volume and cardiometabolic risk factors.
What did we actually find?
Breast volume was not associated with any of the cardiometabolic risk
factors measured in any of the statistical models used. However, in
these analyses, visceral or intra-abdominal fat was a strong predictor
of numerous risk factors – a finding reported in numerous studies.
Next we decided to examine the associations between breast volume and
other body fat depots. Here is where the story got interesting. First
off, as one would predict, women with larger breasts had more
subcutaneous (under the skin) fat in their thighs, abdomen, as well as
more visceral and inter-muscular (or ectopic) fat. That is, bigger
breasted women tended to carry more fat everywhere.
However, once we controlled for their level of obesity (body mass
index and waist circumference) bigger breasted women were no more likely
to have more subcutaneous fat in either lower body or abdomen, but were
much more likely to have excess fat deposition in the dangerous
visceral and inter-muscular depots.
Specifically, our study found that given the same age, body mass
index (total obesity), waist circumference (abdominal obesity), women
with the highest breast volume had approximately 1.1 and 1.3 kg more
visceral fat and intermuscular fat in comparison to women with the
smallest breast volume.
In other words, large breasts appear to indicate a phenotype
characterized by the augmented deposition of fat in ectopic depots, such
as visceral and inter-muscular fat – each of which is independently
associated with increased cardiometabolic risk. The extrapolation of our
findings suggests that excess visceral or intermuscular fat may be the
conduit which explains the previously documented association between
breast size and type-2 diabetes.
While our findings are intriguing (someone at the Obesity Society
conference suggested I should get an award from the most “unique”
study), there exist a couple clinical examples which corroborate our
findings.
For example, approximately 40-50% of women undergoing liposuction of
subcutaneous adipose tissue from the hips, thighs, or abdomen present
with a paradoxical enlargement of breast size of at least one cup as
well as a relative increase in visceral fat post-surgery. Additionally,
highly active antiretroviral therapy among HIV-positive women is
associated with a peripheral loss of functional subcutaneous fat but a
compensatory increase in visceral and intermuscular fat (well documented
lipodystrophy), in association with a significant enlargement in breast
size.
Now before women with large breasts head out to get breast
reductions, it is key to consider that our findings are quite
preliminary, and furthermore that breast size only appears to be a proxy
for other factors which are more likely to be causally related to
health risk. Thus, further research in this area is clearly warranted
before we begin screening disease risk by breast size. Nevertheless,
when explaining our study findings at the conference, I heard many sighs
of relief from women who perceived themselves to have smaller breasts.
Peter
Janiszewski,
P., Saunders, T., & Ross, R. (2009). Breast Volume is an
Independent Predictor of Visceral and Ectopic Fat in Premenopausal Women
Obesity DOI: 10.1038/oby.2009.336
This article was originally posted on Obesitypanacea.com on October 30, 2009, just after the article was published online ahead of print. It was published in paper form earlier this week.
June 3, 2010
June 3, 2010
June 4, 2010
June 10, 2010
June 13, 2010
June 14, 2010
June 17, 2010
June 27, 2010
July 1, 2010